KeyBanc analyst Donald Hooker maintained a Buy rating on Laboratory (LH) today and set a price target of $170.00. The company's shares closed last Friday
Canaccord Genuity analyst Richard Close maintained a Buy rating on Teladoc (TDOC) on March 27 and set a price target of $130.00. The company's shares
Analysts expect Evolent Health Inc (NYSE:EVH) to announce $239.35 million in sales for the current quarter, Zacks reports. Four analysts have made estimates for Evolent Health’s earnings, with the h
ProShare Advisors LLC purchased a new stake in Evolent Health Inc (NYSE:EVH) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 10,042 share
Algert Global LLC purchased a new position in shares of Evolent Health Inc (NYSE:EVH) in the fourth quarter, Holdings Channel reports. The fund purchased 14,333 shares of the technology company’s st
After Needham and Stifel Nicolaus gave Livongo Health (NASDAQ: LVGO) a Buy rating last month, the company received another Buy, this time from Canaccord
There's a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Inovalon (INOV) and Trade Desk (TTD) with bullish
Cowen sees three healthcare IT names poised for rebound Cowen CHNG RCM EVH
Guggenheim Capital LLC lifted its holdings in shares of Evolent Health Inc (NYSE:EVH) by 0.8% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 470,379 share
Envestnet Asset Management Inc. trimmed its position in Evolent Health Inc (NYSE:EVH) by 12.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Comm
Canaccord Genuity analyst Richard Close reiterated a Buy rating on Catasys (CATS) yesterday and set a price target of $26.00. The company's shares closed
New York, March 24, 2020 -- Reportlinker.com announces the release of the report "Global Clinical Risk Grouping Solution Market - Premium Insight, Competitive News Feed.
SAN DIEGO, March 24, 2020 -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in NYSE: EVH shares.  Investors, who purchased shares.
There's a lot to be optimistic about in the Services sector as 2 analysts just weighed in on Five Below (FIVE) and Teladoc (TDOC) with bullish sentiments.
Evolent Health, Inc. (EVH) is now among the bigger bargains in its industry. Within the last year the price ranged from $3.5 – 14.79 and there is a wide opportunity to get in. Its next earnings repo
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE